Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	fructose-bisphosphate aldolase activity	ALDOA ALDOC	5.36e-05	3	85	2	GO:0004332
GeneOntologyMolecularFunction	2-oxoglutarate-dependent dioxygenase activity	PHF2 TMLHE KDM8 TET3	1.70e-04	65	85	4	GO:0016706
GeneOntologyCellularComponent	nuclear body	FMR1 ATR FAM107A SLC34A1 CELF3 ZNF638 UQCC2 KIF18B PQBP1 THAP1 PALB2 TP53 FOXC2 NPAT	1.35e-05	903	84	14	GO:0016604
Domain	FBA_I	ALDOA ALDOC	5.84e-05	3	83	2	IPR000741
Domain	Glycolytic	ALDOA ALDOC	5.84e-05	3	83	2	PF00274
Domain	Aldolase_I_AS	ALDOA ALDOC	5.84e-05	3	83	2	IPR029768
Domain	ALDOLASE_CLASS_I	ALDOA ALDOC	5.84e-05	3	83	2	PS00158
Domain	Znf_C2H2_jaz	ZNF638 ZNF622	4.25e-03	22	83	2	IPR022755
Domain	zf-C2H2_jaz	ZNF638 ZNF622	4.25e-03	22	83	2	PF12171
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIAA1671 TANC2 MDN1 TRIP6 PRRC2C AHNAK CEP192 MAP3K21 CAMSAP2 TP53 KLC3 CRTC2 SAMD4A	1.71e-07	861	85	13	36931259
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	PHF2 TTF2 MDN1 FMR1 ATR AHNAK HNRNPA3 ZNF638 KIF18B INTS3 PQBP1 THAP1 TET3 PALB2 SAMD4A	5.22e-07	1294	85	15	30804502
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	PMS1 PHF2 RBM33 PRRC2C AHNAK HNRNPA3 ZNF638 KIF18B ALDOA PQBP1 TP53 CYB5A NPAT	5.47e-07	954	85	13	36373674
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	KIAA1671 TANC2 MLEC AHNAK WDR35 ZNF638 UQCC2 IFT46 KIF18B MAP3K21 PQBP1 CAMSAP2 TP53 KLC3 CRTC2	6.77e-07	1321	85	15	27173435
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	KIAA1671 TTF2 FLII GRPEL1 RAB3GAP1 MDN1 FMR1 RBM33 TMLHE HNRNPA3 ZNF622 UQCC2 FLG2 SEC63 CYB5A	3.14e-06	1496	85	15	32877691
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PMS1 GRPEL1 ARAP3 FMR1 ATR PRRC2C ZNF638 INTS3 RIOK2 CRTC2	4.31e-06	650	85	10	38777146
Pubmed	The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53.	ATR TP53	5.90e-06	2	85	2	10435622
Pubmed	Hypoxia links ATR and p53 through replication arrest.	ATR TP53	5.90e-06	2	85	2	11865061
Pubmed	mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53.	CLIC4 TP53	5.90e-06	2	85	2	11997498
Pubmed	Mutations of PQBP1 in Renpenning syndrome promote ubiquitin-mediated degradation of FMRP and cause synaptic dysfunction.	FMR1 PQBP1	5.90e-06	2	85	2	28073926
Pubmed	ATR protects the genome against CGG.CCG-repeat expansion in Fragile X premutation mice.	FMR1 ATR	5.90e-06	2	85	2	18160412
Pubmed	JMJD5 interacts with p53 and negatively regulates p53 function in control of cell cycle and proliferation.	KDM8 TP53	5.90e-06	2	85	2	26025680
Pubmed	Structure and expression of mouse aldolase genes. Brain-specific aldolase C amino acid sequence is closely related to aldolase A.	ALDOA ALDOC	5.90e-06	2	85	2	3009179
Pubmed	The increase of cell-membranous phosphatidylcholines containing polyunsaturated fatty acid residues induces phosphorylation of p53 through activation of ATR.	ATR TP53	5.90e-06	2	85	2	18032786
Pubmed	Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma.	USP2 TP53	5.90e-06	2	85	2	27351221
Pubmed	The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies.	INPP5D TP53	5.90e-06	2	85	2	25723258
Pubmed	ATR-p53 restricts homologous recombination in response to replicative stress but does not limit DNA interstrand crosslink repair in lung cancer cells.	ATR TP53	5.90e-06	2	85	2	21857991
Pubmed	PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer.	PHF2 TP53	5.90e-06	2	85	2	25043306
Pubmed	The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression.	ATR TP53	5.90e-06	2	85	2	18089799
Pubmed	Proximal tubule ATR regulates DNA repair to prevent maladaptive renal injury responses.	ATR SLC34A1	5.90e-06	2	85	2	31589169
Pubmed	ATR (ataxia telangiectasia mutated- and Rad3-related kinase) is activated by mild hypothermia in mammalian cells and subsequently activates p53.	ATR TP53	5.90e-06	2	85	2	21284603
Pubmed	A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells.	ATR SEC63 THAP1 TP53 MYBPC1	6.17e-06	105	85	5	23284306
Pubmed	A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis.	SPRY4 ALDOA ALDOC TP53	8.88e-06	53	85	4	38466355
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	FLII ARAP3 ATR PRRC2C AHNAK TP53	1.06e-05	202	85	6	33005030
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	TANC2 TTF2 MDN1 ATR AHNAK HNRNPA3 ZNF638 INTS3 THAP1	1.29e-05	582	85	9	20467437
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	PMS1 FLII FMR1 SLC16A3 TRIP6 HNRNPA3 ZNF638 ZNF622 KDM8 SEC63	1.56e-05	754	85	10	35906200
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TRIP6 RBM33 PRRC2C ZNF638 ZMIZ1 SEC63 CYB5A CRTC2	1.66e-05	457	85	8	32344865
Pubmed	The necdin interactome: evaluating the effects of amino acid substitutions and cell stress using proximity-dependent biotinylation (BioID) and mass spectrometry.	KIAA1671 PRRC2C AHNAK HNRNPA3 CEP192 ALDOA TP53	1.70e-05	330	85	7	32529326
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	KIAA1671 PMS1 TTF2 PRRC2C AHNAK ZNF638 ZNF622 ALDOA ALDOC CAMSAP2 TP53	1.72e-05	934	85	11	33916271
Pubmed	ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells.	ATR TP53	1.77e-05	3	85	2	26563132
Pubmed	Aldolase positively regulates of the canonical Wnt signaling pathway.	ALDOA ALDOC	1.77e-05	3	85	2	24993527
Pubmed	Regulation of male germline transmission patterns by the Trp53-Cdkn1a pathway.	FMR1 TP53	1.77e-05	3	85	2	35931081
Pubmed	ATP depletion triggers acute myeloid leukemia differentiation through an ATR/Chk1 protein-dependent and p53 protein-independent pathway.	ATR TP53	1.77e-05	3	85	2	22621920
Pubmed	The alkylating carcinogen N-methyl-N'-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases.	ATR TP53	1.77e-05	3	85	2	15735814
Pubmed	Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53.	ATR TP53	1.77e-05	3	85	2	19718024
Pubmed	Coupling of Homologous Recombination and the Checkpoint by ATR.	ATR PALB2	1.77e-05	3	85	2	28089683
Pubmed	Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2.	PALB2 TP53	1.77e-05	3	85	2	27490902
Pubmed	DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activation.	ATR TP53	1.77e-05	3	85	2	18434539
Pubmed	Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth.	ALDOA TP53	1.77e-05	3	85	2	29084207
Pubmed	Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.	ATR TP53	1.77e-05	3	85	2	9733515
Pubmed	Human skeletal-muscle aldolase: N-terminal sequence analysis of CNBr- and o-iodosobenzoic acid-cleavage fragments.	ALDOA ALDOC	1.77e-05	3	85	2	6696436
Pubmed	RPA and ATR link transcriptional stress to p53.	ATR TP53	1.77e-05	3	85	2	17616578
Pubmed	The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor.	ZMIZ1 TP53	1.77e-05	3	85	2	17584785
Pubmed	ATM and ATR protect the genome against two different types of tandem repeat instability in Fragile X premutation mice.	FMR1 ATR	1.77e-05	3	85	2	19710035
Pubmed	Mode of interactions of human aldolase isozymes with cytoskeletons.	ALDOA ALDOC	1.77e-05	3	85	2	9244396
Pubmed	TuBG1 promotes hepatocellular carcinoma via ATR/P53-apoptosis and cycling pathways.	ATR TP53	1.77e-05	3	85	2	37806848
Pubmed	XPA-mediated regulation of global nucleotide excision repair by ATR Is p53-dependent and occurs primarily in S-phase.	ATR TP53	1.77e-05	3	85	2	22174788
Pubmed	Identification of ATR-Chk1 pathway inhibitors that selectively target p53-deficient cells without directly suppressing ATR catalytic activity.	ATR TP53	1.77e-05	3	85	2	25336189
Pubmed	Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer.	PALB2 TP53	1.77e-05	3	85	2	23650262
Pubmed	Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites.	ATR TP53	1.77e-05	3	85	2	12959929
Pubmed	s-SHIP associates with receptor complexes essential for pluripotent stem cell growth and survival.	LIFR INPP5D	1.77e-05	3	85	2	17105399
Pubmed	Loss of fragile X protein FMRP impairs homeostatic synaptic downscaling through tumor suppressor p53 and ubiquitin E3 ligase Nedd4-2.	FMR1 TP53	1.77e-05	3	85	2	29771335
Pubmed	The ATR-p53 pathway is suppressed in noncycling normal and malignant lymphocytes.	ATR TP53	1.77e-05	3	85	2	14755251
Pubmed	Phospholipase D2 directly interacts with aldolase via Its PH domain.	ALDOA ALDOC	1.77e-05	3	85	2	11876650
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	TTF2 FLII RAB3GAP1 ARAP3 MDN1 TRIP6 AHNAK HNRNPA3 ZNF638 CLIC4 KIF18B ALDOA RIOK2	2.41e-05	1353	85	13	29467282
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	DNHD1 MDN1 FMR1 AHNAK FLG2 TP53	2.44e-05	234	85	6	36243803
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	KIAA1671 TANC2 FLII ZNF638 PQBP1 RIOK2 CAMSAP2	3.02e-05	361	85	7	30344098
Pubmed	siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.	PALB2 TP53 REV1	3.52e-05	26	85	3	23435420
Pubmed	Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma.	USP2 TP53	3.53e-05	4	85	2	24445145
Pubmed	Reconstitution of human claspin-mediated phosphorylation of Chk1 by the ATR (ataxia telangiectasia-mutated and rad3-related) checkpoint kinase.	ATR TP53	3.53e-05	4	85	2	19828454
Pubmed	Nucleophosmin sets a threshold for p53 response to UV radiation.	ATR TP53	3.53e-05	4	85	2	15082766
Pubmed	TP53-dependent autophagy links the ATR-CHEK1 axis activation to proinflammatory VEGFA production in human bronchial epithelial cells exposed to fine particulate matter (PM2.5).	ATR TP53	3.53e-05	4	85	2	27463284
Pubmed	A positive role for c-Abl in Atm and Atr activation in DNA damage response.	ATR TP53	3.53e-05	4	85	2	20798688
Pubmed	Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR.	ATR TP53	3.53e-05	4	85	2	22133876
Pubmed	Interaction between aldolase and vacuolar H+-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump.	ALDOA ALDOC	3.53e-05	4	85	2	11399750
Pubmed	ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis.	ATR TP53	3.53e-05	4	85	2	16891316
Pubmed	Quantitative nuclear proteomics identifies mTOR regulation of DNA damage response.	ATR TP53	3.53e-05	4	85	2	19955088
Pubmed	DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.	ATR TP53	3.53e-05	4	85	2	22735644
Pubmed	Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner.	ATR TP53	3.53e-05	4	85	2	21098704
Pubmed	Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk.	TP53 REV1	3.53e-05	4	85	2	15609317
Pubmed	ARF and ATM/ATR cooperate in p53-mediated apoptosis upon oncogenic stress.	ATR TP53	3.53e-05	4	85	2	16004968
Pubmed	Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.	PALB2 TP53	3.53e-05	4	85	2	29470806
Pubmed	Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis.	ATR TP53	3.53e-05	4	85	2	18606816
Pubmed	Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation.	ATR TP53	3.53e-05	4	85	2	11459832
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	FLII SLC16A3 TRIP6 PRRC2C AHNAK HNRNPA3 ZNF638 ZNF622 FLG2 ALDOA INTS3 PQBP1 RIOK2	3.83e-05	1415	85	13	28515276
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	DNHD1 FLII USP2 CHST10 RAB3GAP1 ZNF622 CRYZL1 ALDOA TP53	3.88e-05	670	85	9	22990118
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	PHF2 DNHD1 FLII MDN1 FMR1 MLEC ATR HNRNPA3 SEC63 ALDOA ALDOC TP53 MYBPC1	4.12e-05	1425	85	13	30948266
Pubmed	The interactome of the histone gene regulatory factor HiNF-P suggests novel cell cycle related roles in transcriptional control and RNA processing.	TTF2 PRRC2C NPAT	4.92e-05	29	85	3	17577209
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	TRIP6 RBM33 PRRC2C AHNAK HNRNPA3 CRYZL1 TP53	5.68e-05	399	85	7	35987950
Pubmed	Human FEM1B is required for Rad9 recruitment and CHK1 activation in response to replication stress.	FEM1B ATR	5.87e-05	5	85	2	19330022
Pubmed	ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage.	PMS1 TP53	5.87e-05	5	85	2	15226443
Pubmed	ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation.	ATR TP53	5.87e-05	5	85	2	27803059
Pubmed	Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin.	ATR TP53	5.87e-05	5	85	2	28439015
Pubmed	Starvation promotes REV1 SUMOylation and p53-dependent sensitization of melanoma and breast cancer cells.	TP53 REV1	5.87e-05	5	85	2	25614517
Pubmed	Evolutionary implications of the human aldolase-A, -B, -C, and -pseudogene chromosome locations.	ALDOA ALDOC	5.87e-05	5	85	2	3674018
Pubmed	Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration.	PALB2 TP53	5.87e-05	5	85	2	35404932
Pubmed	GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth.	FMR1 TP53	5.87e-05	5	85	2	29606348
Pubmed	Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains.	PALB2 TP53	5.87e-05	5	85	2	31877165
Pubmed	SIRT7-dependent deacetylation of NPM promotes p53 stabilization following UV-induced genotoxic stress.	ATR TP53	5.87e-05	5	85	2	33495326
Pubmed	Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor.	ATR TP53	5.87e-05	5	85	2	15775976
Pubmed	Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.	ATR TP53	5.87e-05	5	85	2	18642075
Pubmed	HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity.	TNK2 TP53	5.87e-05	5	85	2	23402884
Pubmed	Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.	ATR TP53	5.87e-05	5	85	2	10859164
Pubmed	Hypoxia activates tumor suppressor p53 by inducing ATR-Chk1 kinase cascade-mediated phosphorylation and consequent 14-3-3γ inactivation of MDMX protein.	ATR TP53	5.87e-05	5	85	2	22556425
Pubmed	BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.	ATR TP53	5.87e-05	5	85	2	15159397
Pubmed	DNA replication stress-induced phosphorylation of cyclic AMP response element-binding protein mediated by ATM.	ATR TP53	5.87e-05	5	85	2	16293623
Pubmed	DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair.	ATR TP53	5.87e-05	5	85	2	22797063
Pubmed	Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.	LIFR TP53	5.87e-05	5	85	2	30996350
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	AHNAK HNRNPA3 ZNF638 TP53	6.06e-05	86	85	4	37253089
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	KIAA1671 PHF2 ZNF827 HNRNPA3 ZNF638 TNK2 CEP192 ZMIZ1 ZNF839 INTS3 SHROOM2 TET3 CYB5A	6.44e-05	1489	85	13	28611215
Interaction	CEP128 interactions	KIAA1671 TTF2 TRIP6 ZNF622 IFT46 CEP192 CAMSAP2 TP53 DEUP1	4.49e-06	297	85	9	int:CEP128
Interaction	KIF13B interactions	TANC2 ZNF638 MAP3K21 CAMSAP2 KLC3 CRTC2	3.05e-05	142	85	6	int:KIF13B
Interaction	WDR47 interactions	FMR1 FAM107A CAMSAP2 TP53	3.21e-05	43	85	4	int:WDR47
Interaction	FHL2 interactions	KIAA1671 SLC34A1 PRRC2C SPRY4 ZNF638 MAP10 MYBPC1 BAHCC1 REV1	4.40e-05	396	85	9	int:FHL2
Interaction	CDC25C interactions	TANC2 GRPEL1 ZNF638 MAP3K21 CAMSAP2 TP53	5.16e-05	156	85	6	int:CDC25C
Interaction	BRCA1 interactions	DNHD1 FLII USP2 GRPEL1 MDN1 ATR ZNF827 AHNAK HNRNPA3 CRYZL1 ZMIZ1 ALDOA MAP3K21 PALB2 TP53 REV1	5.83e-05	1249	85	16	int:BRCA1
Interaction	ZBTB21 interactions	TANC2 ZNF638 MAP3K21 CAMSAP2 TP53 CRTC2	6.15e-05	161	85	6	int:ZBTB21
Interaction	TRIM37 interactions	FLII ZNF550 FAM107A SLC16A3 TRIP6 AHNAK CEP192 ALDOA MAP10 CAMSAP2 TP53	6.68e-05	630	85	11	int:TRIM37
Interaction	KCTD3 interactions	TANC2 ZNF638 MAP3K21 CAMSAP2 KLC3 CRTC2	6.82e-05	164	85	6	int:KCTD3
Interaction	HINFP interactions	TTF2 PRRC2C TP53 NPAT	7.37e-05	53	85	4	int:HINFP
Interaction	REV3L interactions	PMS1 FAM107A TP53 REV1	9.16e-05	56	85	4	int:REV3L
Interaction	GIGYF1 interactions	TANC2 FEM1B ZNF638 MAP3K21 CAMSAP2 CRTC2	1.04e-04	177	85	6	int:GIGYF1
Interaction	CEP152 interactions	KIAA1671 TTF2 MLEC CEP192 TP53 DEUP1	1.10e-04	179	85	6	int:CEP152
Interaction	RPA4 interactions	KIAA1671 MDN1 PRRC2C AHNAK HNRNPA3 ZNF638 SEC63 ALDOA TP53	1.21e-04	452	85	9	int:RPA4
Interaction	CBY1 interactions	TANC2 ZNF638 MAP3K21 CAMSAP2 KLC3 CRTC2	1.21e-04	182	85	6	int:CBY1
ToppCell	metastatic_Brain\|World / Location, Cell class and cell subclass	MLEC SLC16A3 PLPP2 TRIP6 ARX ALDOA CYB5A	1.10e-07	199	85	7	a6793145de96bcdbfd4fe04159e34ea2244ca5a8
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PMS1 DNHD1 FAM107A ZMIZ1 MAP10	1.81e-05	169	85	5	8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST10 NRCAM FAM107A ALDOC MYBPC1	2.66e-05	183	85	5	25c96df8ea0c7bbedbb7699ee84ad6234d19cba8
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST10 NRCAM FAM107A ALDOC MYBPC1	2.80e-05	185	85	5	dbbd348714cd16a4948a04648e914b1e71e2a8ef
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST10 NRCAM FAM107A ALDOC MYBPC1	2.80e-05	185	85	5	bea69058afa5aa927fe15c1f8d46460562ec4dd4
ToppCell	CV-Moderate-4\|Moderate / Virus stimulation, Condition and Cluster	SLC16A3 PLPP2 TRIP6 ALDOA ALDOC	2.80e-05	185	85	5	4a3ce0c603c2ffe11f0f00775b6af4f6d9a6070a
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIAA1671 ARAP3 FAM107A PLPP2 CLIC4	2.95e-05	187	85	5	d9d10ed7c905778a29a0dc3ced3eef02a6b1de5c
ToppCell	CD8+_Memory_T_cell-CV-4\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	SLC16A3 PLPP2 TRIP6 ALDOA ALDOC	2.95e-05	187	85	5	9c2fc2f259fa7d3a65fb99c295ac378e03d9aa6c
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 ARAP3 FAM107A SCN4A TRDN	3.18e-05	190	85	5	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZCCHC24 NRCAM SPRY4 TNK2 ALDOC	3.18e-05	190	85	5	6c7e1086c0a274cd5527c3104106e372811c9905
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	NRCAM VSIG10 SHROOM2 CYB5A ACSS3	3.34e-05	192	85	5	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	KIAA1671 LIFR ARAP3 PCDH11X SHROOM2	3.42e-05	193	85	5	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 PLPP2 TNK2 ALDOC KLC3	3.42e-05	193	85	5	22ebc3f586eb0aabc5785e468c88d7416c624ff4
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP2 PLPP2 TNK2 ALDOC KLC3	3.51e-05	194	85	5	0ef63abcfd057079a9a6f8b27404ff521d44845d
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZCCHC24 NRCAM SPRY4 TNK2 ALDOC	3.69e-05	196	85	5	f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZCCHC24 NRCAM SPRY4 TNK2 ALDOC	3.69e-05	196	85	5	671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCell	droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLPP2 TNK2 VSIG10 ALDOC KLC3	3.69e-05	196	85	5	9554ac6eb5f381bcde3ba40c32aa3fc340974540
ToppCell	droplet-Mammary_Gland-nan-18m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP2 PLPP2 TNK2 ALDOC KLC3	3.78e-05	197	85	5	ed3a37f532741764060d297a560eeeeec279d9c4
ToppCell	metastatic_Brain-Epithelial_cells\|metastatic_Brain / Location, Cell class and cell subclass	MLEC PLPP2 TRIP6 ALDOA CYB5A	3.96e-05	199	85	5	5c0cd611dbf2014e0ae6ce9fe8b619ceb4006e43
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZCCHC24 NRCAM SPRY4 TNK2 ALDOC	3.96e-05	199	85	5	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	metastatic_Brain-Epithelial_cells-Malignant_cells\|metastatic_Brain / Location, Cell class and cell subclass	MLEC PLPP2 TRIP6 ALDOA CYB5A	3.96e-05	199	85	5	56df2b342c77b33299cfb407e1e05f42940f2946
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TANC2 ZCCHC24 NRCAM TNK2 ALDOC	3.96e-05	199	85	5	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZCCHC24 NRCAM SPRY4 TNK2 ALDOC	3.96e-05	199	85	5	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Mesenchymal-Unfolded_protein_responsible_cell\|2m / Sample Type, Dataset, Time_group, and Cell type.	ZNF550 MLEC ZNF622 ALDOA ALDOC	4.06e-05	200	85	5	1b08c1be05e2a6a05d8ea35d9a745c4b1809a1b2
Drug	Ichiba acid	ALDOA ALDOC	1.38e-05	2	85	2	CID000440403
Drug	3-HM	ALDOA ALDOC	1.38e-05	2	85	2	CID000439464
Drug	bromohydroxyacetone phosphate	ALDOA ALDOC	1.38e-05	2	85	2	CID000152675
Drug	anthracene diol	ALDOA ALDOC	1.38e-05	2	85	2	CID000155464
Drug	trimethylaminobutyraldehyde	TMLHE ALDOA ALDOC	3.29e-05	17	85	3	CID000000133
Drug	cupric oxide	PMS1 ZNF550 ATR AHNAK KIF18B ALDOA MAP3K21 ALDOC THAP1 TP53	3.45e-05	543	85	10	ctd:C030973
Drug	2-keto-3-deoxy- l-lyxonate	ALDOA ALDOC	4.12e-05	3	85	2	CID000192781
Drug	4-fluorothreonine	ALDOA ALDOC	4.12e-05	3	85	2	CID000128057
Drug	(4S,7R,8R,9R,13Z,16S)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-1-oxacyclohexadec-13-ene-2,6-dione	ALDOA ALDOC	4.12e-05	3	85	2	CID009869661
Drug	acetol phosphate	ALDOA ALDOC	4.12e-05	3	85	2	CID000150865
Drug	androisoxazole	ALDOA ALDOC	4.12e-05	3	85	2	CID000009676
Drug	2-keto-3-bromobutyrate	ALDOA ALDOC	4.12e-05	3	85	2	CID000191968
Drug	3-isochromanone	ALDOA ALDOC	4.12e-05	3	85	2	CID000078092
Drug	3,3,3-trifluoropropanoic acid	ALDOA ALDOC	4.12e-05	3	85	2	CID002777972
Drug	5-deoxy-5-fluoro-L-sorbose	ALDOA ALDOC	4.12e-05	3	85	2	CID000191809
Drug	D-ribulose-1-p	ALDOA ALDOC	4.12e-05	3	85	2	CID000000615
Drug	4-hydroxy-9-fluorenone	ALDOA ALDOC	4.12e-05	3	85	2	CID000016139
Drug	AC1L19ID	ALDOA ALDOC	4.12e-05	3	85	2	CID000000560
Drug	4-hydroxy-2-ketopimelate	ALDOA ALDOC	4.12e-05	3	85	2	CID000000553
Drug	AC1L19F1	ALDOA ALDOC	4.12e-05	3	85	2	CID000000519
Drug	Htfp	ALDOA ALDOC	4.12e-05	3	85	2	CID000125055
Drug	DIDIT	ALDOA ALDOC	4.12e-05	3	85	2	CID000196082
Drug	C11 -427	ALDOA ALDOC	4.12e-05	3	85	2	CID000443195
Drug	9-fluorenone-1-carboxylic acid	ALDOA ALDOC	8.22e-05	4	85	2	CID000074083
Drug	C06441	ALDOA ALDOC	8.22e-05	4	85	2	CID000441020
Drug	formylacetate	ALDOA ALDOC	8.22e-05	4	85	2	CID000075269
Drug	3-hydroxy-1-indanone	ALDOA ALDOC	8.22e-05	4	85	2	CID000176448
Drug	l-123	ALDOA ALDOC	8.22e-05	4	85	2	CID000093552
Drug	phenanthrene trans-3,4-dihydrodiol	ALDOA ALDOC	8.22e-05	4	85	2	CID000119398
Drug	DHMP	ALDOA ALDOC	8.22e-05	4	85	2	CID000098784
Drug	dihydroxyacetone sulfate	ALDOA ALDOC	8.22e-05	4	85	2	CID000439751
Drug	AC1L9A8P	ALDOA ALDOC	8.22e-05	4	85	2	CID000440943
Drug	Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; MCF7; HT_HG-U133A	TANC2 ZCCHC24 PHF2 NRCAM KDM8 NPAT	8.61e-05	193	85	6	1703_UP
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A	ZCCHC24 RAB3GAP1 SLC16A3 PRRC2C INPP5D IFT46	8.86e-05	194	85	6	1264_DN
Drug	Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; HL60; HT_HG-U133A	USP2 NRCAM INPP5D KDM8 CAMSAP2 SAMD4A	9.64e-05	197	85	6	2380_UP
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; HL60; HG-U133A	FEM1B SLC16A3 INPP5D CAMSAP2 ACSS3 BAHCC1	9.91e-05	198	85	6	2005_UP
Drug	estradiol, USP; Up 200; 0.01uM; HL60; HG-U133A	FEM1B FMR1 PRRC2C AHNAK CLIC4 ALDOC	9.91e-05	198	85	6	782_UP
Drug	deoxyribose	ALDOA ALDOC REV1	1.09e-04	25	85	3	CID000010786
Drug	NSC 724998	ATR TP53	1.37e-04	5	85	2	ctd:C553898
Drug	1,3-dioxan-5-one	ALDOA ALDOC	1.37e-04	5	85	2	CID009793707
Drug	AC1L4F2K	ALDOA ALDOC	1.37e-04	5	85	2	CID000184526
Drug	alpha-methylserine	ALDOA ALDOC	1.37e-04	5	85	2	CID000094309
Drug	gamma-oxalocitramalate	ALDOA ALDOC	1.37e-04	5	85	2	CID000000130
Drug	phosphoglycollamide	ALDOA ALDOC	1.37e-04	5	85	2	CID000191768
Drug	D-erythrulose 1-phosphate	ALDOA ALDOC	1.37e-04	5	85	2	CID000152153
Drug	2,3-dihydroxy-p-cumate	ALDOA ALDOC	1.37e-04	5	85	2	CID000029587
Drug	f-3p	ALDOA ALDOC	1.37e-04	5	85	2	CID015991581
Drug	AC1NX490	ALDOA ALDOC	1.37e-04	5	85	2	CID005743230
Drug	hydroxypyruvaldehyde phosphate	ALDOA ALDOC	1.37e-04	5	85	2	CID000193787
Drug	mycestericin D	ALDOA ALDOC	2.05e-04	6	85	2	CID006439504
Drug	2,2-dimethyl-1,3-dioxan-5-one	ALDOA ALDOC	2.05e-04	6	85	2	CID002733141
Drug	2-(N-decyl)aminonaphthalene-6-sulfonic acid	ALDOA ALDOC	2.05e-04	6	85	2	CID000189836
Drug	propyltrimethoxysilane	ALDOA ALDOC	2.05e-04	6	85	2	CID000061254
Drug	AC1L18Q4	ALDOA ALDOC	2.05e-04	6	85	2	CID000000210
Drug	parapyruvate	ALDOA ALDOC	2.05e-04	6	85	2	CID000440249
Drug	7-oxoheptanoic acid	ALDOA ALDOC	2.05e-04	6	85	2	CID000169732
Drug	acetyldithio-CoA	ALDOA ALDOC	2.05e-04	6	85	2	CID003082679
Drug	0 Gz	ALDOA ALDOC	2.05e-04	6	85	2	CID000000372
Drug	chloroacetol phosphate	ALDOA ALDOC	2.05e-04	6	85	2	CID000168137
Drug	C02783	ALDOA ALDOC	2.05e-04	6	85	2	CID000439805
Drug	benzyloxyacetaldehyde	ALDOA ALDOC	2.05e-04	6	85	2	CID000108989
Drug	Chlorpyrifos	USP2 NRCAM MLEC SLC16A3 INPP5D SPRY4 ZNF622 KDM8 ZMIZ1 VSIG10 SEC63 TP53	2.28e-04	960	85	12	ctd:D004390
Drug	Aldol	TMLHE ALDOA ALDOC	2.53e-04	33	85	3	CID000007897
Drug	5-deoxy-D-xylulose-1-phosphate	ALDOA ALDOC	2.86e-04	7	85	2	CID000192931
Drug	2-indanone	ALDOA ALDOC	2.86e-04	7	85	2	CID000011983
Drug	Z-Glu-Tyr	ALDOA ALDOC	2.86e-04	7	85	2	CID000096820
Drug	acenaphthenone	ALDOA ALDOC	2.86e-04	7	85	2	CID000075229
Drug	carboxylin	ALDOA ALDOC	2.86e-04	7	85	2	CID003082458
Drug	C0447	ALDOA ALDOC	2.86e-04	7	85	2	CID000128786
Drug	B-N6	ALDOA ALDOC	2.86e-04	7	85	2	CID015942653
Drug	glycidol phosphate	ALDOA ALDOC	2.86e-04	7	85	2	CID000152659
Drug	DAPpNP	ALDOA ALDOC	2.86e-04	7	85	2	CID005492375
Drug	AC1L4RUE	MLEC CYB5A	2.86e-04	7	85	2	CID000191084
Disease	Growth abnormality	ZMIZ1 TET3	2.46e-05	3	85	2	C0262361
Disease	Neoplasm of uncertain or unknown behavior of ovary	PMS1 ATR TP53	7.99e-05	29	85	3	C0496920
Disease	Ovarian Carcinoma	PMS1 ATR TP53	8.85e-05	30	85	3	C0029925
Disease	3- 4-hydroxyphenyl lactate measurement	SLC16A3 TRDN	1.71e-04	7	85	2	EFO_0021008
Disease	Urologic Neoplasms	ATR TP53	2.27e-04	8	85	2	C0042076
Disease	endometrial cancer (implicated_via_orthology)	ATR TP53	2.27e-04	8	85	2	DOID:1380 (implicated_via_orthology)
Disease	syndromic X-linked intellectual disability (implicated_via_orthology)	PHF2 ARX	2.27e-04	8	85	2	DOID:0060309 (implicated_via_orthology)
Disease	Cancer of Urinary Tract	ATR TP53	2.27e-04	8	85	2	C0751571
Disease	Pancreatic carcinoma, familial	PALB2 TP53	2.91e-04	9	85	2	C2931038
Disease	folic acid measurement	PHF2 KDM8 DEUP1	3.20e-04	46	85	3	EFO_0005111
Disease	Dental enamel hypoplasia	ZMIZ1 MAP3K21	5.31e-04	12	85	2	EFO_1001304
Disease	Malignant neoplasm of ovary	PMS1 ATR FAM107A TP53	6.73e-04	137	85	4	C1140680
Disease	Hereditary Breast and Ovarian Cancer Syndrome	PALB2 TP53	7.30e-04	14	85	2	C0677776
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DNHD1 AHNAK RIOK2 TP53	8.98e-04	148	85	4	C0279702
Disease	Colorectal Carcinoma	LIFR ARAP3 NRCAM PCDH11X ZMIZ1 PQBP1 CAMSAP2 TP53	9.49e-04	702	85	8	C0009402
Disease	Cardiovascular Abnormalities	ZMIZ1 FOXC2	9.59e-04	16	85	2	C0243050
Disease	Malignant neoplasm of endometrium	PMS1 ATR	1.22e-03	18	85	2	C0007103
Disease	Carcinoma in situ of endometrium	PMS1 ATR	1.22e-03	18	85	2	C0346191
Disease	Testicular Germ Cell Tumor	SPRY4 ZNF638 CLUL1	1.24e-03	73	85	3	EFO_1000566
Disease	Cleft palate, cleft lip	TANC2 PHF2 NOG SLC16A3 SAMD4A	1.29e-03	279	85	5	EFO_0003959, HP_0000175
Disease	Ovarian Failure, Premature	NOG FMR1	1.66e-03	21	85	2	C0085215
Disease	QRS duration, response to sulfonylurea	MDN1 ZNF638	1.99e-03	23	85	2	EFO_0005055, EFO_0007922
Disease	Glioma	ATR FAM107A TP53	2.05e-03	87	85	3	C0017638
Disease	Uterine leiomyoma	TP53 REV1 NPAT	2.33e-03	91	85	3	HP_0000131
Disease	breast cancer (implicated_via_orthology)	ATR TP53	2.36e-03	25	85	2	DOID:1612 (implicated_via_orthology)
Disease	peripheral arterial disease, traffic air pollution measurement	TANC2 SLC16A3 PLPP2 SLC34A1	2.42e-03	194	85	4	EFO_0004265, EFO_0007908
Disease	cerebral amyloid deposition measurement	ARAP3 TRDN SAMD4A	2.64e-03	95	85	3	EFO_0007707
Disease	Hereditary non-polyposis colorectal cancer syndrome	PMS1 PALB2	2.75e-03	27	85	2	C1112155
Disease	Malignant tumor of breast	PALB2 TP53	2.75e-03	27	85	2	cv:C0006142
Disease	Breast neoplasm	PALB2 TP53	2.75e-03	27	85	2	cv:C1458155
Disease	gamma-glutamyltyrosine measurement	ZMIZ1 TRDN	2.75e-03	27	85	2	EFO_0021144
Disease	Familial cancer of breast	PALB2 TP53	2.75e-03	27	85	2	cv:C0346153

Protein segments in the cluster

Peptide	Gene	Start	Entry
KPPKAELIAIDPHAA	ERICH6	316	Q7L0X2
QHLDLEEPAQEKAPK	BAHCC1	951	Q9P281
HKEDLRDGLPVLIPK	BAHCC1	1906	Q9P281
VGQIPRHLEEKDLKP	CELF3	11	Q5SZQ8
PLNGLKEEDKEPLIE	CLIC4	6	Q9Y696
EHGELERPLHPKEKV	ARAP3	1171	Q8WWN8
IVEPEILPDGDHDLK	ALDOC	186	P09972
IVEPEILPDGDHDLK	ALDOA	186	P04075
KGPKIDVDAPDIDIH	AHNAK	3256	Q09666
DIDIHGPDAKLKGPK	AHNAK	3266	Q09666
HLRLKEEKAPGPEDL	DNHD1	2231	Q96M86
PRKELPHLKEEIPFE	DEUP1	121	Q05D60
HKIDKEGERLPRPED	TNK2	341	Q07912
FPNPEDKKLEEIIHQ	RAB3GAP1	821	Q15042
PLHKVLPIKPADVEE	RBM33	926	Q96EV2
KDDEPAVKLQLLPHK	CRYZL1	231	O95825
RLNQLEKPPEKEEDH	FAM107A	106	O95990
AHLAPLFDNPKLDKE	INTS3	471	Q68E01
GEKHKEEPIDIIKAP	NPAT	1276	Q14207
QELHKLLDKDPDLPV	ARL10	166	Q8N8L6
LLEKELHPVLKNPDD	FLG2	36	Q5D862
ENPLEIKEKPEEAGH	MDN1	4906	Q9NU22
LGGEPSEIKKHVPED	FLII	706	Q13045
DKPLGELEIPEAQKD	MAP10	231	Q9P2G4
PLHDPDLDFLEVAKK	KIAA1671	336	Q9BY89
HELGPLVDLKIPANK	NRCAM	996	Q92823
EEKLHKPPADSGVDL	SLC16A3	426	O15427
PKEEIKDDNPHLKNL	GRPEL1	126	Q9HAV7
LQPHPGLEKKEEEEE	MLEC	221	Q14165
DHGLIPDVKLEKTVP	KDM8	171	Q8N371
DGDNILEKEVLPPIH	FEM1B	286	Q9UK73
IGELHPDDRPKLNKP	CYB5A	81	P00167
ELYKEILHKEDLPAP	KLC3	396	Q6P597
EKEERAHLKEPPPAA	FOXC2	176	Q99958
EENLRKKGEPHHELP	TP53	286	P04637
IKEPLDREETPNHKL	PCDH11X	311	Q9BZA7
PPQHCLKEEELERKP	PLPP2	251	O43688
EQIHDLLEPKGPLAI	KIF18B	161	Q86Y91
HEPLPAKLALEEEQK	SLC34A1	71	Q06495
LEEDLIVLPGKSHPK	PALB2	671	Q86YC2
LAKRGILKHLEPEPE	PQBP1	11	O60828
PDHPELKKIKAVLQE	ATR	1256	Q13535
GPNAPEEKKHLDIKE	FMR1	346	Q06787
QLIDLDHKLKPFIPD	IFT46	91	Q9NQC8
PKVPAIEENLLDDKH	CRTC2	211	Q53ET0
PKEELLLHPEDAEGK	ARX	291	Q96QS3
DPKNLLLKPGEEHEV	CEP192	1696	Q8TEP8
NKKEPEKLPDHVPLF	C2orf50	101	Q96LR7
PEDSHLEKEPLEKFP	SDHAF4	61	Q5VUM1
LLENHKLPAEPLEKP	PMS1	761	P54277
LEQRGHNPEEKEIKP	CAMSAP2	1061	Q08AD1
EIPDPQHKAEIRLDK	LIFR	586	P42702
LIEHPDPIFDPKEKD	NOG	46	Q13253
LDLKGPAVPPELDKH	SPRY4	141	Q9C004
ELPEHFKPSQLIKDL	PHF2	421	O75151
EPPEEDLKKDNHILN	SCN4A	881	P35499
ELHKAQAAEEPLPKE	MAP3K21	741	Q5TCX8
LPDLSPVENKEHKPG	PRRC2C	2101	Q9Y520
EDKVKALLHEGPESP	INPP5D	276	Q92835
PALPHGLEKDQIKTL	SHROOM2	1236	Q13796
EPLENLHKERKIPDE	TANC2	521	Q9HCD6
ALDPPGDKAKVLEVH	ARHGAP4	311	P98171
PLVEEALKIGQHKPD	ACSS3	236	Q9H6R3
RKLPEEKHIPEELKP	CHST10	51	O43529
EKHIPEELKPTGKEL	CHST10	56	O43529
AIEDLPKQDKAPDHG	CLUL1	276	Q15846
PPEDELDRLTKKLVH	TRIP6	251	Q15654
FLKHEGPPAEKPLEE	REV1	1116	Q9UBZ9
PHDKKEDLLEPQEQL	THAP1	86	Q9NVV9
LQEKFAPKGPEEDHK	UQCC2	111	Q9BRT2
PLKLEVHEAKPVPEN	SEC63	711	Q9UGP8
HDPKEPEQLRKLFIG	HNRNPA3	26	P51991
VGKIPEDEQLHVLPL	TET3	1101	O43151
LHPLGPDDKNIETKE	RIOK2	316	Q9BVS4
EFLRKKEIHPDNLGP	ZNF839	446	A8K0R7
KEEIPDPDVKGSPHL	ZNF827	466	Q17R98
PKPELVHLLEHGQEL	ZNF550	56	Q7Z398
GEIDEPPLRKKEIHK	TRDN	131	Q13061
EREELPKEIPKQDHI	VSIG10	486	Q8N0Z9
HKEGEDPNKAEELPS	ZNF622	356	Q969S3
KSNPENLDHLPDDEK	USP2	381	O75604
VLLDEILKDPEHPNK	WDR35	646	Q9P2L0
PEEFELLSKVPLKHE	TMLHE	286	Q9NVH6
HLPLLKPGNLDAKVE	SAMD4A	86	Q9UPU9
EHDPELEKESPGLKN	ZNF638	1091	Q14966
PIKSDLHIKDDPDGI	ZMIZ1	826	Q9ULJ6
EDPAGLKVPLLLHQK	TTF2	561	Q9UNY4
PHKQRPLEKPDGLDV	ZCCHC24	201	Q8N2G6
VHVIDPPKIILDGLD	MYBPC1	516	Q00872